
    
      Study type:

      Interventional Allocation: Randomized Endpoint Classification: Efficacy Study Intervention
      Model: Parallel Assignment Masking: only Investigator Primary Purpose: Prevention Study
      Phase: Phase 4

      Conditions or Focus of the study: Post ERCP pancreatitis

      Intervention information

        -  Intervention Names ERCP

        -  Arm Information

             -  Arm 1:Ceftazidime

             -  Arm 2 (active comparator): Diclophenac potassium
    
  